Neogen Chemicals Ltd Q2 FY2024 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/f5dcaa3ubnl70fp348ap2llz.pdf

Key Takeaways


Battery Business Build-Out

Harin Kanani: "we felt that instead of 10,000 tonnes, when we go to 30,000 MT, the capex does not become three times, right? There is a significant saving when we do further scale-up. So by doing that our capex efficiency per tonne improves. And therefore, our ability to be more competitive improves."

Customer Qualification & Go-to-Market

Harin Kanani: "Almost all geographies are very keen to have a non-China Electrolyte salt supplier. So what was our plan B is becoming almost like plan A."

Legacy Business: Quarter Performance


Demand Environment & Headwinds


Technology & Competitive Position

Harin Kanani: "scientists, be it industry veterans, none of them see solid-state becoming a significant play before 2030."

Capital Allocation & Returns Framework

Harin Kanani: "I think this is a business where ROE and ROCE, are going to be the key factors. We would like ROCE to be upward of 20%. We like to model and try to get prices of ROCE above 20%."

Guidance & Commitments

CommitmentSpecificsTimeline
Electrolyte salt trial stabilizationPhase 1 trial production to stabilize; Phase 2 ready by end of DecemberDecember 2023
Electrolyte salt customer approvalsBegin receiving approvals for saltsQ4 FY24
Electrolyte sales start2,000 MT own-technology line installed and sales beginQ4 FY24 or Q1 FY25
Mitsubishi design freeze & capex clarityExact capex number to be provided once Mitsubishi finishes designDecember 2023 / before February call
Greenfield site operational30,000 MT electrolyte and 3,000 MT salt capacity commissionedCalendar year 2025 (Q2/Q3 FY26)
Total battery capex deployment₹900–₹1,100 crore spent across remaining FY24, FY25, and two to three quarters of FY26Second half of FY26
Debt-equity ceilingWill evaluate raising funds or partner options if ratio approaches 1.25xOngoing
Battery business ROCE targetPre-tax ROCE upward of 20%At commercialization

Key Metrics

MetricQ2 FY24
Consolidated revenue₹161.7 cr, +9% YoY
Organic Chemicals revenue₹124 cr, +24% YoY
Inorganic Chemicals revenue₹39 cr, -21% YoY
Domestic revenue mix69% of total revenue
Export revenue mix31% of total revenue
EBITDA₹25.9 cr, +7% YoY
PAT₹7.9 cr, -20% YoY
FY24 revenue guidance₹800 cr at ~18% EBITDA margin, looks difficult to achieve; H1 FY24 revenue was ~₹335 cr
Organic Chemicals installed capacity463 m³ as on date; additional 29 m³ expected by end of FY24
Inorganic Chemicals installed capacity39 m³ as on date, including 15 m³ reactor capacity added till March 2023
Lithium Electrolyte Salts trial production400 MTPA capacity, one section commenced trial production
Electrolyte Salts capacity target4,000 MT total (1,000 MT existing site + 3,000 MT greenfield), up from 2,000 MT earlier plan
Electrolyte capacity target32,000 MT total (2,000 MT own technology + 30,000 MT MUIS technology), up from 10,000 MT earlier plan
Battery chemicals capex estimate₹900–₹1,100 cr, 2 to 2.5 times the earlier ₹450 cr plan, spread over 7–8 quarters ending H2 FY26
Preferential allotment raised₹253 cr on 1st November 2023
Target debt-equity ratio1.25
ROCE target for battery chemicals20%+ pre-tax